Although human papillomavirus (HPV) has been defined as the pathogen for cervical carcinomas, molecular events underlying the oncogenic process are unclear. As telomere dysfunction-mediated chromosomal instability and telomerase activation have been suggested as key events in carcinogenesis, we dissected the dynamic changes in telomere length, checkpoint response, and temporal profile of telomerase expression during the evolution from precursor lesions (cervical intraepithelial neoplasia, CINs) to invasive cancers of the uterine cervix in sequential samples from 16 patients. Telomeres were significantly shortened in all CIN samples and no further substantial attritions occurred in most cases with the acquisition of malignant phenotype. Very short telomeres were coupled with constitutive activation of the DNA damage response pathway (Chk2 phosphorylation) and increased cellular proliferation in those cervical specimens. Telomerase reverse transcriptase (hTERT) expression was preferably induced at advanced CINs or invasive cancers. The present finding demonstrates that excessive telomere shortening predominantly occurs in the early carcinogenesis of the uterine cervix largely prior to telomerase activation. Widespread over-erosion of telomeres or telomere dysfunction in very early stages of cervical tumorigenesis might fuel transformation processes by driving chromosomal instability.
Although human papillomavirus (HPV) has been defined as the pathogen for cervical carcinomas, molecular events underlying the oncogenic process are unclear. As telomere dysfunction-mediated chromosomal instability and telomerase activation have been suggested as key events in carcinogenesis, we dissected the dynamic changes in telomere length, checkpoint response, and temporal profile of telomerase expression during the evolution from precursor lesions (cervical intraepithelial neoplasia, CINs) to invasive cancers of the uterine cervix in sequential samples from 16 patients. Telomeres were significantly shortened in all CIN samples and no further substantial attritions occurred in most cases with the acquisition of malignant phenotype. Very short telomeres were coupled with constitutive activation of the DNA damage response pathway (Chk2 phosphorylation) and increased cellular proliferation in those cervical specimens. Telomerase reverse transcriptase (hTERT) expression was preferably induced at advanced CINs or invasive cancers. The present finding demonstrates that excessive telomere shortening predominantly occurs in the early carcinogenesis of the uterine cervix largely prior to telomerase activation. Widespread over-erosion of telomeres or telomere dysfunction in very early stages of cervical tumorigenesis might fuel transformation processes by driving chromosomal instability. Keywords: cervical cancer; HPV; genomic instability; telomere erosion; telomerase The development of cervical carcinomas, intimately associated with infection of high-risk or oncogenic types of human papillomavirus (HPV), represents a typical multi-step transformation process (zur Hausen, 2002; Burd, 2003; Fehrmann and Laimins, 2003) . It is known that oncogenic HPV viral proteins first initiate precursor lesions (cervical intraepithelial neoplasia, CINs) of the uterine cervix by interacting with and inactivating the tumor suppressors p53 and pRb, two essential players in the induction of cellular senescence, and of cell growth arrest and/or apoptosis in response to various genetic insults (zur Hausen, 2002; Burd, 2003; Fehrmann and Laimins, 2003) . Disabling the p53 and pRb pathways therefore allow cells to enter and proceed through cell cycle under conditions that increase the frequencies of aneuploidy and large-scale chromosomal structural alterations such as genome amplification, deletion, and translocation, characteristic of chromosomal instability. With the accumulation of genetic aberrations, CIN may eventually achieve a fully malignant end point in years or decades.
Chromosomal instability, the dominant type of human cancer genomes persistently observed in cervical and various other epithelial carcinomas, has been proposed as a key driving force for neoplastic development (Lengauer et al., 1998; Chang et al., 2001) . Much effort has therefore been expended to delineate the underlying mechanisms, the molecular basis of which remains elusive. Recently, telomere attrition/dysfunction seems to emerge as one of the prime triggers for complex chromosomal abnormalities occurring in carcinogenesis (Chang et al., 2001; Hackett and Greider, 2002; Hahn, 2003; Der-Sarkissian et al., 2004) .
It has long been appreciated that telomeres, the nucleoprotein complex consisting of up to 15 kb TTAGGG repeat sequences and associated proteins, form protective caps on chromosome ends and are essential to genomic stability/integrity (Hackett and Greider, 2002; Hahn, 2003) . Telomeric DNA is synthesized by telomerase, an RNA-dependent DNA polymerase that is generally silent in normal human somatic cells due to stringent repression of the human telomerase reverse transcriptase (hTERT) gene encoding the catalytic component of telomerase (Shay et al., 2001; Hahn, 2003) . Owing to the 'end replication problem', plus a lack of telomerase activity in normal somatic cells, progressive telomere shortening occurs with each round of cellular divisions. Cells are triggered to enter a permanent growth arrest stage named 'replicative senescence' when their telomeres reach a critical size that elicits the DNA damage checkpoint response or p53 and pRb activation (Chang et al., 2001; Hahn, 2003) . It is suggested that the senescence program act as a potent barrier to cancer development. However, under certain circumstances such as the inactivation of the tumor suppressors p53 and pRb, cells are capable of continuing to replicate even if their telomere length is well below the threshold for induction of senescence and bypassing senescence limitation, which consequently leads to excessive telomere erosions, losses of telomere capping function, and eventual chromosomal aberrations, a required genotype during oncogenesis (Chang et al., 2001; Hahn, 2003) . Such genomic instability induced by telomere dysfunction has precisely been recapitulated in in vitro human cell culture models (Counter et al., 1992; Der-Sarkissian et al., 2004) . Further convincing evidence has come from telomerase-deficient p53 mutant mice where very short telomeres are observed to trigger complex nonreciprocal chromosomal translocations, regional genome amplification and deletion through breakage-fusion-bridge (BFB) cycles, coupled with enhanced incidence of malignancies, particularly epithelial carcinomas (Artandi et al., 2000; Rudolph et al., 2001; O'Hagan et al., 2002) .
However, this scenario has been poorly documented during in vivo human oncogenesis, presumably due to the impossibility of using forward genetics and technical difficulties as well. A few groups have recently shown telomere over-erosion even in the early stages of oncogenic process of prostate and pancreatic tissues by using novel quantitative fluorescence in situ hybridization (Q-FISH) that measures telomere length at single cell levels van Heek et al., 2002; Vukovic et al., 2003) . Given the oncogenic HPV as the defined pathogen and a stepwise development of cervical cancers (zur Hausen, 2002; Burd, 2003; Fehrmann and Laimins, 2003) , they provide an ideal in vivo model to address these important issues. Sampling of specimens from precursor lesions and later stages during carcinoma development in the same individual enables the investigation of dynamic changes in telomere length and a temporal relationship with telomerase activation during in vivo cervical carcinogenesis.
The present study included 16 patients (Table 1) and, by using the Q-FISH as described (van Heek et al., 2002) , we determined the telomere size in sequential samples from those individuals at different stages of cervical oncogenesis. In normal cervical tissues, telomere signals differ slightly, with stroma fibroblasts possessing stronger telomere fluorescence intensities than epithelial cells (Figure 1 and data not shown). Compared to stroma cells, the epithelial cells in the precursor lesion area from all CIN samples exhibited significantly weaker telomere hybridization signals (Table 1, Figures 1-3 ). With the disease progression into more advanced stages of CINs or carcinomas, telomere shortening was similarly observed in the vast majority of patients (Table 1, Figure 2 ). In the samples from patient No. 2, EP: epithelial cells. Telomere length was assessed by using Q-FISH van Heek et al., 2002) . The 4 mm thick cervical sections were deparaffinized, followed by dehydration in graded ethanol, pepsin digestion, and hybridized with FITC-labeled PNA telomere probe (CCCTAA)3. The nuclei were counterstained with DAPI. The samples were evaluated under a Zeiss epifluorescence microscope equipped with the corresponding wavelength filter, CCD camera, and an image capturing and analysing system. Threedimensional image volumes of the hybridized metaphases measuring 768 Â 768 Â 5 pixels were obtained using a Delta Vision system (Applied Precision Inc, Issaquah, WA, USA). (b) Immunohistochemistry staining for Chk2 phosphorylation in normal-CIN1 (left panel) and CIN2 (right panel). Arrow: transitional areas between normal tissues and CIN1 precursor lesions. (c) Immunohistochemistry staining for PCNA in normal-CIN1 (left panel) and CIN2 (right panel). Arrow: transitional areas between normal tissues and CIN1 precursor lesions. Immunohistochemical staining, as described earlier (Zhang et al., 2000 (Zhang et al., , 2002 , was performed on serial cervical sections parallel to those used for the telomere length analysis. Following deparaffinization, antigen unmasking, and inactivation of endogenous peroxidase, the primary antibodies against phosphorylated Chk2 (Cell Signaling Technology, 1 : 50 dilution) or PCNA (Santa Cruz. 1 : 100 dilution) were added and incubated at 41C overnight. An antibody binding was visualized by using the secondary antibodies conjugated with horseradish peroxidase and an AEC kit, according to the manufacturers' protocols (Dako Corporation). The slides were finally counterstained with hematoxylin and evaluated under microscopes
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A Zhang et al however, we found strikingly weaker signals at the CIN stage, whereas 25-fold stronger than normal telomere fluorescence intensity when an invasive cancer developed ( Figure 3) . Interestingly, from a pathological standpoint, the precursor lesions in patient No. 4 were stable at CIN2 stage within 8 years; however, telomere length as shown by Q-FISH was very different between these two samples, indicating that the premalignant cells had undergone more molecular or genetic alterations despite unchanged histological manifestations. Inconsistent changes in telomere length were found when these patients' disease evolved from the precursor lesions to invasive carcinomas, but in most patients no further telomere shortening occurred with acquisition of invasive cancers. When patient No. 2 with extremely long telomeres in her tumor cells was excluded, the cells derived from CIN and invasive carcinoma samples carried comparable amounts of telomere signals (CINs vs carcinomas, 0.1670.03 vs 0.1570.05, P ¼ 0.71).
Among CINs, there seemed a tendency with increased telomere erosions in higher stages of CINs; however, such a difference was not significant, either.
As hTERT is the rate-limiting component for telomerase activity control, and its induction is usually accompanied by telomerase activation, we further investigated telomerase expression in all available samples by performing hTERT protein analysis using an immunohistochemical assay. hTERT protein was undetectable in normal cervical epithelial cells. Similarly, all the samples at stage 1 CIN were negative for hTERT expression. In contrast, a positive hTERT protein staining was found in 3/8 CIN2, 5/8 CIN3, and 10/11 invasive cancers (Table 1, Figures 1 and 2) . Interestingly, the cancer sample from patient No. 2, although harboring much stronger telomere signals than their adjacent normal cells, lacked detectable hTERT protein, suggesting the activation of an alternative mechanism for telomere lengthening (Figure 3) . The diagnoses of CINs and invasive squamous cell carcinomas were established based on the International Federation of Genecology and Obstetrics.
b Telomere hybridization was performed, and the maximum intensity projections of the acquired images were analysed using the IMP image-processing software (the Center for Image Analysis at Uppsala University, Uppsala, Sweden) (Zhang et al., 2003) . Telomere signals in 10 nuclei from normal or different pathological regions were measured separately, and then normalized by DAPI fluorescence intensity in corresponding areas as described van Heek et al., 2002) . The telomere length in CIN or cancer cells was arbitrarily expressed as ratios of the specific telomere fluorescent signals between them and adjacent normal stroma cells.
c Immunohistochemistry staining. The result was scored according to both staining intensities and positive cell numbers, which were categorized as follows: (a) À, no expression; (b) +, weak expression; (c) ++, moderate expression, and (d) +++, strong expression. In vitro studies of human cultured cells indicate that critically shortened telomeres mimic double-stranded DNA breaks (DSBs), thereby activating the DNA damage response through the ATM-p53 pathway (Karlseder et al., 1999; Pandita, 2002) . Since Chk2 is an essential mediator between ATM and p53, and its activation occurs upon telomere shortening in senescent human fibroblasts and heart failure (DiTullio et al., 2002; Fagagna Fd et al., 2003; Oh et al., 2003) , we thus sought to determine whether and how the DNA checkpoint responded to telomere erosions in precursor and malignant lesions by assessing the phosphorylated Chk2 at Thr68. There was no detectable phosphoryla- tion of Chk2 protein in normal areas of all the samples, whereas a positive staining was seen in 11/20 of CINs and 9/10 of invasive cancers, respectively, which suggests a constitutive activation of the DNA damage response pathway. Although Chk2 activation was more frequently observed in CIN3 (6/8) and carcinomas, it did occur in nearly half of CIN1 (2/5) and CIN2 (3/7). Figure 1 showed a typical example where Chk2 was phosphorylated in CIN1 while not in the adjacent normal epithelial cells, and the disease progression into CIN2 led to further significant increases in Chk2 phosphorylation. Likely, p53 is the downstream effector in transducing telomere-shortening signals through the ATM-Chk2 pathway. We are thus further interested in p53 status and its relationship with Chk2 activation in the cervical samples. As shown in Table 1 , the p53 protein was infrequently detectable in all the stages of CINs (5/22), and only 4/10 of invasive carcinomas exhibited a positive staining for p53 despite a high frequency of Chk2 phosphorylation. This result suggests a disruption of the DNA damage checkpoint pathway, presumably due to the degradation of p53 by the HPV oncogenic protein during cervical carcinogenesis.
Telomere exhausts in human somatic cells result predominantly from cellular replications. We then determined cell proliferation rate in the precursor lesions and cervical cancers by analysing the proliferative cell nuclear antigen (PCNA) protein expression, an established proliferative marker. Normal cervical epithelial cells were in general negative for PCNA protein staining, while a significantly increased PCNA expression was observed in 13/23 CIN samples and all 10 cancers (Table 1, Figures 1 and 2 ). The data clearly show an accelerated replication rate of both premalignant and malignant cells, coupled with observed telomere erosions.
By using the Q-FISH that assesses telomere length at the single-cell level (van Heek et al., 2002) , combined with the sequential samples from the same individuals that represent different stages of in vivo cervical carcinogenesis, we have observed a predominant occurrence of telomere erosions in the precursor lesion of the cervical tissues. According to animal experiments and in vitro transformation models, telomere over-erosion triggers the formation of telomeric fusions between chromosome arms, and those abnormal chromosomes further form bridges that may consequently break and lead to chromosome rearrangements by fusion of broken ends, the so-called BFB cycles (Chang et al., 2001) . Such continuous re-organization of cellular genome eventually creates novel molecular events essential for fully malignant transformation. Although we were unable to sort out those individual cells carrying very weak telomere signals to perform comparative genomic hybridization due to technical difficulties, based on previous observations showing a high frequency of chromosomal aberrations in CINs (Southern et al., 1997; Aubele et al., 1998; Evans et al., 1998; Giannoudis et al., 2000; Umayahara et al., 2002; Heselmeyer-Haddad et al., 2003; Pihan et al., 2003) , it is rational to attribute genomic alterations to substantial telomere loss in those precursor lesions of the uterine cervix. Taken together, we suggest that telomere shortening and the resultant genetic instability may be key events in the formative stages of cervical cancers, which is consistent with those seen in animal and in vitro human tumorigenic models.
On the other hand, however, despite a pivotal role for telomere shortening-mediated genomic aberrations in initial phases of carcinogenesis, this unstable status, if beyond intolerable levels, will certainly compromise tumor development and progression. To overcome this backdrop, the mechanism to stabilize telomere sizes is usually acquired in transformed cells (Shay et al., 2001; Hahn, 2003) . It has been shown that telomerase reactivation/hTERT expression, responsible for elongation of telomeric DNA sequences, widely occurs in the vast majority of human tumor cell lines and primary malignancies including cervical carcinomas as well (Anderson et al., 1997; Kyo et al., 1997; Snijders et al., 1998; Takakura et al., 1998; Jarboe et al., 2002; Hahn, 2003) . Consistently, we detected the presence of hTERT protein in 10/11 of invasive cancer samples. A positive hTERT staining was also observed in 3/8 of CIN2 and 3/7 of CIN3, but none of CIN1 samples. This result, together with the presence of very short telomeres in the premalignant cells at stage I CIN, indicates a time lag between telomere erosion and the onset of telomerase activation. Conceivably, the time lag allows accelerated telomere loss in the very early stage of cervical carcinogenesis. However, even if there was a widespread activation of telomerase in invasive carcinomas, malignant cells harbored abnormally short telomeres comparable with those in their own precursors (P ¼ 0.71), which provides evidence that telomerase acquired in those cells is only capable of maintaining telomere equilibrium at shortened levels rather than leading to further net lengthening of TTAGGG sequences.
Interestingly, we identified the presence of alternative lengthening for telomeres (ALT), an alternative mechanism for telomere extension in the sample from one patient with invasive cancer. The patient's malignant cells exhibited abnormally longer telomeres, whereas they expressed undetectable hTERT protein. However, significant telomere erosion was found in the premalignant cells obtained from this same patient when her disease was in CIN2 stage. This result demonstrates that ALT, like telomerase, is activated in rather late phases of cervical oncogenesis.
The present study revealed a close correlation between hTERT induction and higher proliferation rates in CINs and carcinomas. A potential explanation for this could be an accelerated telomere loss in highly replicative cells, and very short telomeres then drive telomerase activation through undefined mechanisms, as seen in in vitro cultured cells surviving the crisis phase. Consistent with the reactivation model of telomerase, normal epithelium, the target for transformation, expresses undetectable hTERT protein by using the current immunohistochemical staining. Alternatively, increased proliferation activity may be associated with more HPV loads that directly or indirectly activate telomerase in precursor and malignant lesions via various mechanisms (Klingelhutz et al., 1996; Veldman et al., 2001; Zhang et al., 2002; Ferber et al., 2003; McMurray and McCance, 2003) .
Chk2 is involved in the DNA damage signal transduction pathway between ATM and p53, and is phosphorylated/activated by ATM upon DNA damage or threshold levels of telomeres (DiTullio et al., 2002; Fagagna Fd et al., 2003; Oh et al., 2003) . The widespread Chk2 activation observed in cervical carcinomas represents the presence of DNA damage and genetic instability (DiTullio et al., 2002) . Interestingly, Chk2 could even be activated in stage 1 CIN, the earliest stage of precursor lesions. In that setting, critically short telomeres and resultant genetic alterations are likely to be important triggers for DNA damage checkpoint response. As the function of p53, the downstream target of ATM and Chk2, is frequently abolished by HPV oncogenic proteins in CIN and cervical carcinomas, which in turn compromises p53-mediated growth arrest and apoptosis of cells harboring genetic defects including telomere over-erosions, accumulation of those abnormal cells will continue despite a strong upstream DNA damage checkpoint response. Likewise, the constitutive DNA damage pathway activation in both CIN and cervical cancers selects for p53 inactivation. With the disease progression from CINs to carcinomas, Chk2 phosphorylation was substantially elevated, indicating ongoing and more severe genomic instability or damage presumably through the BFB cycle.
In summary, we have studied the temporal sequence of telomere shortening, DNA damage checkpoint activation, and telomerase expression during in vivo development of cervical cancers. Our findings suggest that CIN1 is the critical stage where telomere shortening/dysfunction occurs during cervical carcinogenesis. The constitutive Chk2 activation in precursor lesions further indicates the presence of DNA damage and genetic abnormalities including excessive telomere erosions. hTERT protein was induced following substantial losses of telomeric DNA. Accumulation of various genetic events, together with activation of telomerase, may eventually drive full transformation of uterine cervix with invasive and metastatic features. Future studies should be aimed to directly delineate a causal relationship between telomere erosions and chromosomal instability in cervical carcinogenesis.
